Nylim US LG Ca R&D LD ETF-UiLRNDETF
13F holders, Q4 2025 (December 31)5holders +3
2new positions
0sold out
$40.76avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Nylim US LG Ca R&D LD ETF-Ui (LRND) in their 13F filings, up 3 from Q3 2025. 2 opened new positions and 0 sold out. The largest holders were New York Life Investment Management LLC ($65.4M), GTS Securities LLC ($538K) and Bank of America Corp. ($285K).
- Company
- Nylim US LG Ca R&D LD ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q4 2025)
- CUSIP
- 45409B263
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $298K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 1,422,221 shares bought, net +1,422,221 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| New York Life Investment Management LLC | 0.56% | Add +744.6% | 1,604,816 | $65.4M |
| GTS Securities LLC | 0.02% | Add +0.8% | 13,193 | $538K |
| Bank of America Corp. | 0.00% | New | 6,982 | $285K |
| Sankala Group LLC | 0.02% | — | 577 | $23K |
| Assetmark, Inc. | 0.00% | New | 317 | $13K |
"% of holder's portfolio" is LRND's weight in each manager's 13F, not the share of Nylim US LG Ca R&D LD ETF-Ui the manager owns.